Gregory Scott Duncan - 26 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role: Director
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Issuer symbol: CRMD
Transactions as of: 26 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 27 Jan 2026, 21:30:02 UTC
Previous filing: 05 Dec 2025
Next filing: 06 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Duncan Gregory Scott	Director	C/O CORMEDIX INC., 389 INTERPACE PKWY, SUITE 450, PARSIPPANY	/s/ Beth Zelnick Kaufman, attorney-in-fact	27 Jan 2026	0001831127

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRMD	Common Stock	Award	$0	+30,453	+79%	$0.000000	68,786	26 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.

Remarks:

Exhibit 24.1 - Power of Attorney